News Center

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) reported second-quarter 2026 financial and operational results, including a 53% year-over-year reduction in operating expenses to $2.29 million and a 47% decrease in general and administrative expenses to $1.76 million. Combined cash, cash equivalents and digital […]

For development-stage medical technology companies, regulatory approval and commercial revenue often sit years apart. A trial needs to be finished, a submission must clear review, manufacturing has to scale, surgeons must be trained and distribution has to be built. Companies able to run those workstreams in parallel rather than in sequence compress the distance between […]

Beeline Holdings (NASDAQ: BLNE) reported second-quarter 2026 net revenue of $2.6 million, up 57% year over year, as its net loss narrowed to $4 million from $5.3 million in the first quarter and its adjusted EBITDA loss improved to $2.6 million from $3 million. Operating margins increased 9.4% from the previous quarter, while the company ended […]

AirAsia Group Berhad (
cAirAsia Group
d or
cthe Group
d, formerly known as AirAsia X Berhad) today reported its unaudited financial results for the second quarter of 2026 ended 30 June 2026 (
c2Q26
d), demonstrating proactive management execution and tactical agility in navigating a volatile global energy environment.

On August 13, JD.com announced its unaudited financial results for the three months and six months ended June 30, 2026. Below is an infographic with the key highlights. Take a dive into the full report.

SS Innovations International (NASDAQ: SSII) reported record second-quarter 2026 revenue of $13.9 million, up 39.4% from $10 million a year earlier, as installations of its SSi Mantra surgical robotic system increased 30.4% to 30. Gross profit rose 20% to $7.1 million, with gross margin of 50.9%, while net loss was $2.7 million, or $0.01 per […]

Aging populations are pushing joint disease higher on the orthopedic agenda, with cartilage damage representing one of the field’s largest unmet needs. Current treatments have demonstrated clinical utility, but they remain difficult to deliver efficiently and economically on scale. That gap is where off-the-shelf therapies can deliver high value, and where manufacturing know-how and intellectual […]

Wrap Technologies (NASDAQ: WRAP) and XINSURANCE announced a strategic partnership to develop and bring to market the WRAP Safe Response Program, a certified operating standard for organizations that employ or contract security personnel. The program is designed to establish a documented standard for training, equipment and response before encounters escalate, targeting a U.S. workforce of approximately 1.28 million security […]

BOXABL (NASDAQ: BXBL) announced the launch of a new section of its website aimed at encouraging partnerships to assemble the capabilities needed to make housing affordable at mass-production scale. The company is seeking opportunities across four primary categories — companies, land, talent and inventions — and identified potential partners including manufacturers, installers, developers, landholders, logistics operators, lenders, dealer networks, automation and software providers and materials suppliers. […]

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Multiple sclerosis is quietly shifting how drugmakers define success. Instead of judging a therapy mainly by whether it reduces relapses, developers are chasing the slower, harder-to-treat processes that drive long-term disability, and Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) is one of the companies […]